| phase I trial |
The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. ...
Ãâó: www.stjude.org/glossary
|
|---|---|
| phase I trial |
The first stage in testing a new drug in humans. The studies are usually done to gather preliminary information on the chemical action and safety of the drug using healthy volunteers. Usually done without a comparison group.
Ãâó: www.aegis.com/pubs/cria/2003/CR030902.html
|
| phase I trial |
In these trials, a small number of patients are given a new treatment to determine the safety of the treatment, including appropriate dosage levels. Because many of the treatments researched in phase I trials are new, participants may face substantial risks. Therefore, these trials are usually open only to patients in an advanced stage of cancer, whose disease is not controllable with standard treatment.
Ãâó: nydailynews.healthology.com/nydailynews/15836.htm
|
| phase I trial |
Clinical trial conducted to find the safest dose and most effective way to give a new cancer treatment to patients, as well as identify potential side effects. Phase I trials are usually limited to a small number of patients who would not be helped by other known treatments.
Ãâó: www.melanomacenter.org/glossary/p.html
|
| phase I trial |
Study of a small group of patients to determine the side effects of a new treatment, with escalating intensity of the treatment administered.
Ãâó: dfw-neuronetwork.com/Glossary.htm
|